Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by gltainv on Sep 23, 2024 7:40am

Hopefully

Am I the only one confused on the difference of pre BTD and BTD? Hopefully whatever they want us to complete doesn't get more hurdles thrown in. That could be the make or break, especially in terms of the funding. I think management will be fighting tooth and nail soon to try to get this done.
Comment by gltainv on Sep 23, 2024 7:41am
To add to that, what are the different credentials needed to get BTD from pre? I feel like I've seen it before but it's been so long I have no idea now. 
Comment by DJDawg on Sep 23, 2024 8:53am
My reading of the FDA website suggests that pre-BTD is a process where you run your application by a designated reviewer who tells you whether likely to fly or not. So not a complex thing but rather a short way of the FDA saving yours and their time by telling you to proceed with BTD or not. TLT has always called this pre-BTD and no one else does that I can tell. I assume that there is enough ...more  
Comment by Dumbeldorfwhite on Sep 23, 2024 9:12am
Here we are probably late again. At least TLt is consistent missing dealines.
Comment by GhostWriter82 on Sep 23, 2024 10:49am
Dumb, you have zero reason lob out a negative sentiment around the BTD submission ... other than to instill fear to those hanging off every comment. Save it for a few more weeks, then let loose.
Comment by chry200030 on Sep 23, 2024 10:54am
It's not a matter of IF but WHEN now. I certainly would not want to be a seller at this stage when things are about to get interesting...
Comment by Dumbeldorfwhite on Sep 23, 2024 2:40pm
Ok sheep, not sure you re mad at me when it's the COMPANY that comes up with THESE deadlines. Maybe they should have been more upfront with things. Instead let me fill you in on how this works. TLT says they ll do something in so and so quarter. Quarter passes and don't here anything. Then slyly in the bottom of the quarterly it's pushed back another quarter. No explanation.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250